2012 || Pharmaceuticals || Rectal Cancer – Pipeline Review, H2 2012 || Aarkstore.com

1. Rectal Cancer – Pipeline Review, H2 2012
Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Rectal Cancer – Pipeline Review, H2 2012
RSS link of Global Markets Direct
Summary
Global Markets Direct’s, Rectal Cancer - Pipeline Review, H2 2012, provides an
overview of the Rectal Cancer therapeutic pipeline. This report provides
information on the therapeutic development for Rectal Cancer, complete with latest
updates, and special features on late-stage and discontinued projects. It also reviews
key players involved in the therapeutic development for Rectal Cancer. Rectal
Cancer - Pipeline Review, H2 2012 is built using data and information sourced from
Global Markets Direct’s proprietary databases, Company/University websites, SEC
filings, investor presentations and featured press releases from company/university
sites and industry-specific third party sources, put together by Global Markets
Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Rectal Cancer.
- A review of the Rectal Cancer products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined

2. Rectal Cancer – Pipeline Review, H2 2012
therapeutics.
Table of contents:
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Rectal Cancer Overview 9
Therapeutics Development 10
An Overview of Pipeline Products for Rectal Cancer 10
Rectal Cancer Therapeutics under Development by Companies 12
Rectal Cancer Therapeutics under Investigation by Universities/Institutes 14
Late Stage Products 21
Comparative Analysis 21
Mid Clinical Stage Products 22
Comparative Analysis 22
Early Clinical Stage Products 23
Comparative Analysis 23
Pre-Clinical Stage Products 24
Comparative Analysis 24
Rectal Cancer Therapeutics – Products under Development by Companies 25
Rectal Cancer Therapeutics – Products under Investigation by
Universities/Institutes 26
Companies Involved in Rectal Cancer Therapeutics Development 34
F. Hoffmann-La Roche Ltd. 34
Abbott Laboratories 35
Sanofi-Aventis 36
Merck & Co., Inc. 37
ImClone Systems Incorporated 38
Merck KGaA 39
Zenotech Laboratories Limited 40
Corporacion Parc Tauli 41
Isofol Medical AB 42
Rectal Cancer – Therapeutics Assessment 43
Assessment by Monotherapy Products 43
Assessment by Combination Products 44

3. Rectal Cancer – Pipeline Review, H2 2012
Assessment by Route of Administration 45
Assessment by Molecule Type 47
Drug Profiles 49
Stimuvax - Drug Profile 49
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1
Myocardial Infarction – Pipeline Review, H2 2012
Metastatic Liver Cancer – Pipeline Review, H2 2012
Mantle Cell Lymphoma – Pipeline Review, H2 2012
Malignant Mesothelioma – Pipeline Review, H2 2012
Rectal Cancer – Pipeline Review, H2 2012
Chemotherapy Effects – Pipeline Review, H2 2012
Follicular Lymphoma – Pipeline Review, H2 2012
Sleep Disorders – Pipeline Review, H2 2012

4. Rectal Cancer – Pipeline Review, H2 2012
Neuroblastoma – Pipeline Review, H2 2012
Cytomegalovirus (HHV-5) Infections – Pipeline Review, H2 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com